Key result
Very-early discharge (≤ 48 h) after primary percutaneous coronary intervention in low-risk STEMI patients was safe, with 0% major adverse cardiac events occurring within 6 months.
Why the study?
The study assessed the safety and efficacy of very-early discharge within 48 hours after primary PCI in low-risk STEMI patients compared with standard discharge.
Does very-early discharge (≤ 48 h) after successful primary percutaneous coronary intervention maintain safety in low-risk STEMI patients compared to standard discharge?
Cohort
Does very-early discharge (≤ 48 h) after successful primary percutaneous coronary intervention maintain safety in low-risk STEMI patients compared to standard discharge?
Very early discharge (≤ 48 h) after successful primary PCI is feasible and safe for low-risk STEMI patients, with no MACCE at 6 months.
Answers are grounded in this paper and cite their sources.
Supports feasibility of very-early discharge in low-risk STEMI post-PCI; hypothesis-generating and requires randomized confirmation before practice change.
This VEDLOR-STEMI study assessed the safety and efficacy of very-early discharge (VED- ≤ 48 h) after primary percutaneous coronary intervention (PPCI) for patients with ST elevation myocardial infarction who are considered low risk and compared their outcome with low-risk patients who had standard discharge protocol. No major adverse cardiac events (MACCE) occurred within 6 months. Minor complications, like access site pain were managed without readmission. High patient satisfaction (97.3 %) was noted, with 48 % actively utilizing a hotline for queries. VED post-PPCI appears feasible and safe with appropriate discharge protocols and follow-up.
No takes yet. Share an insight, caveat, or question.
Showkathali et al. (2025) conducted a cohort in ST elevation myocardial infarction. Very-early discharge (≤ 48 h) vs. Standard discharge protocol was evaluated on Major adverse cardiac events (MACCE) within 6 months. Very-early discharge (≤ 48 h) after primary percutaneous coronary intervention in low-risk STEMI patients was safe, with 0% major adverse cardiac events occurring within 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: